Current position:Home >Product >
N-(7-chloro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide
N-(7-chloro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide(864082-48-4)
- Name: N-(7-chloro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide
- Synonyms:GSK466317A;864082-48-4;N-(7-chloro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide;3-Pyridinecarboxamide, N-(7-chloro-1H-indazol-5-yl)-1,4,5,6-tetrahydro-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-;CHEMBL427058;SCHEMBL3886838;BDBM14056;dihydropyridone indazole amide 16;DTXSID001106992;HMS3303D04;HMS3305P17;NSC756175;AKOS040748478;NSC-756175;NCGC00241939-01;AB01092190-01;N-(7-Chloro-1H-indazol-5-yl)-1,4,5,6-tetrahydro-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-3-pyridinecarboxamide;N-(7-Chloro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide;N-(7-chloro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyridine-3-carboxamide
- Molecular Formula:C21H16ClF3N4O2
- Molecular Weight:448.8
- CAS Registry Number:864082-48-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.864082-48-4 GSK466317A
Assay:98% Appearance:Powder Package:inquiry Storage:-20鈩?Freezer Transportation:inquiry Application:GSK466317A is a G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1184914-21-3/1-(3-Chloropyrazin-2-yl)-1-(oxolan-3-yl)methanamine
- 70753-50-3/2,17-Dichloro-4,19-dithia-15,30-diazaheptacyclo[16.12.0.03,16.05,14.06,11.020,29.021,26]triaconta-1(30),2,5(14),6,8,10,12,15,17,20(29),21,23,25,27-tetradecaene
- 756525-89-0/Bis-(1,13-(3-maleimidopropionyl)amido)-4,7,10-trioxatridecane
- 448211-44-7/4,4,5,5-Tetramethyl-2-(6-methylcyclohex-1-en-1-yl)-1,3,2-dioxaborolane
- 57794-18-0/beta-D-Desosamine
- 1261928-64-6/3-(3-Cyanophenyl)-5-methoxybenzoic acid
- 1187929-47-0/2-Fluoro-4-trifluoromethyl-benzamidine hydrochloride
- 1216276-20-8/2-(N-Boc-aminomethyl)-5-(trifluoromethyl)pyridine
- 6337-13-9/3-(Dibromomethyl)-6h-anthra[9,1-cd][1,2]thiazol-6-one
- 914266-02-7/N-[[4-(4-fluorophenyl)-5-[4-[oxo-(propan-2-ylamino)methyl]-2-thiazolyl]-2-oxazolyl]methyl]carbamic acid tert-butyl ester
- 2231764-75-1/6Ryw63P5NH
- 618102-64-0/3-(4-Bromophenyl)-1-(3-chloro-4-fluorophenyl)-1H-pyrazole-5-carboxylic acid
- 1457497-47-0/5-Cyclobutoxy-2-(propan-2-yl)pyrimidine-4-carboxylic acid
- 1260656-96-9/5-Chloro-1,8-naphthyridin-4(1H)-one
- 30153-46-9/4-Bromo-2,3-dimethylthiophene
- 144631-82-3/4-Bromo-6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
- 1781244-56-1/Lansoprazole thiadiazine impurity
- 1417644-40-6/2-Bromo-5-methoxypyridin-4-amine
- 1367369-79-6/(1S,3S,4R)-Entecavir
- 864082-48-4/N-(7-chloro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide
- 1807518-78-0/Propargyl-PEG1-SS-PEG1-t-butyl ester
- 756413-36-2/2-(pyrrolidin-3-yl)-1H-benzo[d]imidazole
- 667412-92-2/4-cyano-5-[(cyanoacetyl)amino]-N,N,3-trimethylthiophene-2-carboxamide
- 2100306-50-9/N-(Azido-PEG3)-N-Fluorescein-PEG3-acid
- 262352-32-9/Robustaside D
- 1363378-15-7/(R)-Tetrahydrofuran-3-carbonitrile
- 1000697-60-8/7,7-Dimethyl-3-[(4-methyl-1,3-thiazol-5-yl)methyl]-7,8-dihydro-2H-1-benzopyran-2,5(6H)-dione
- 1007541-96-9/5-ethyl-1-methyl-1H-pyrazole-4-carboxylic acid
- 1059605-02-5/mPEG14-OH
- 1160264-72-1/2-(2,5-Dimethylphenyl)quinoline-4-carbonyl chloride